Tianjin Chase Sun Pharmaceutical News

Tianjin Chase Sun Pharmaceutical: tianjin chase sun pharmaceutical co., ltd.'s announcement on the results of the "21 chase sun 01" put option and delisting.

Aug 21 04:48 ET

Tianjin Chase Sun Pharmaceutical: Tianjin Chase Sun Pharmaceutical Co., Ltd. announced the payment of interest for the 2024 public issuance of corporate bonds (first tranche) targeted towards professional investors in 2021.

Aug 21 04:48 ET

Tianjin Chase Sun Pharmaceutical: CSI Enterprise Bond Index's Tianjin Chase Sun Pharmaceutical publicly issued corporate bonds (first phase) for professional investors in 2021. This report is for the entrusted management affairs (2023).

Jun 27 04:43 ET

Tianjin Chase Sun Pharmaceutical: Tianjin Hongri Pharmaceutical Co., Ltd. 2024 Follow-up Rating Report

May 30 04:30 ET

Hongri Pharmaceutical: Tianjin Hongri Pharmaceutical Co., Ltd.\'s public issuance of corporate bonds to professional investors in 2021 (first phase), 2023 interest payment announcement

Aug 18, 2023 04:39 ET

Hongri Pharmaceutical: Tianjin Hongri Pharmaceutical Co., Ltd. publicly issued corporate bonds to professional investors in 2021 (Phase 1) fiduciary management report (2022)

Jun 29, 2023 04:01 ET

Hongri Pharmaceutical: Tianjin Hongri Pharmaceutical Co., Ltd. publicly issued corporate bonds 2023 tracking rating report

May 29, 2023 06:39 ET

Hongri Pharmaceutical: Tianjin Hongri Pharmaceutical Co., Ltd. publicly issued corporate bonds to professional investors in 2021 (first phase) 2022 interest payment announcement

Aug 18, 2022 04:26 ET

Hongri Pharmaceutical: Tianjin Hongri Pharmaceutical Co., Ltd.'s 2021 Public Issuance of Corporate Bonds to Professional Investors (Phase I) Fiduciary Management Report (2021)

Jun 29, 2022 07:12 ET

Red Sun Pharmaceutical: Tianjin Red Sun Pharmaceutical Co., Ltd. 2022 Follow-up Rating Report

May 30, 2022 05:36 ET

Red Sun Pharmaceutical: 2021 Annual Equity Distribution Implementation Notice

May 11, 2022 12:00 ET

Red Sun Pharmaceutical: Announcement on the Company's Additional Public Issuance of Corporate Bonds (Phase I) to Professional Investors in 2021 to Raise Funds to Supervise Banks

Sep 29, 2021 23:49 ET

Hongri Pharmaceutical: Announcement on the listing of Tianjin Hongri Pharmaceutical Co., Ltd.'s public offering of corporate bonds (first phase) to professional investors on the Shenzhen Stock Exchange in 2021

Aug 26, 2021 05:37 ET

Hongri Pharmaceutical: Announcement on the results of the public issuance of corporate bonds (first phase) by Tianjin Hongri Pharmaceutical Co., Ltd. to professional investors in 2021

Aug 23, 2021 05:31 ET

Hongri Pharmaceutical: Tianjin Hongri Pharmaceutical Co., Ltd.\'s 2021 Public Offering of Corporate Bonds (Phase I) Coupon Interest Rate Announcement to Professional Investors

Aug 19, 2021 08:18 ET

Hongri Pharmaceutical: Announcement on Extending the Bookkeeping and Filing Period for Tianjin Hongri Pharmaceutical Co., Ltd.\'s Public Issuance of Corporate Bonds (Phase I) to Professional Investors in 2021 (Third Time)

Aug 19, 2021 08:06 ET

Hongri Pharmaceutical: Announcement on extending the bookkeeping and filing period for the public issuance of corporate bonds (first phase) by Tianjin Hongri Pharmaceutical Co., Ltd. to professional investors in 2021 (second time)

Aug 19, 2021 06:13 ET

Hongri Pharmaceutical: Announcement on extending the bookkeeping and filing period for the public issuance of corporate bonds (first phase) by Tianjin Hongri Pharmaceutical Co., Ltd. to professional investors in 2021

Aug 19, 2021 04:00 ET

Hongri Pharmaceutical: Credit Rating Report for the Public Issuance of Corporate Bonds by Tianjin Hongri Pharmaceutical Co., Ltd. to Professional Investors in 2021

Aug 18, 2021 04:35 ET

Hongri Pharmaceutical: Tianjin Hongri Pharmaceutical Co., Ltd. publicly issued corporate bonds (first phase) to professional investors in 2021 (subject to this)

Aug 18, 2021 04:35 ET